CAR-T Therapy Clinical Trials
9 recruitingDrug
Phase 14Early Phase 12Phase 21
Showing 1–9 of 9 trials
Recruiting
Phase 2
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
Lymphoma
M.D. Anderson Cancer Center40 enrolled1 locationNCT06218602
Recruiting
Phase 1
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital27 enrolled1 locationNCT06822881
Recruiting
Early Phase 1
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07339332
Recruiting
Early Phase 1
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
SSc-Systemic Sclerosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07355972
Recruiting
Phase 1
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
CD7+ T-ALL/LBL
Peking University People's Hospital18 enrolled1 locationNCT07280494
Recruiting
Phase 1
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07031713
Recruiting
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Multiple Myeloma (MM)Multiple Myeloma, Relapsed
Sung-Soo Park174 enrolled1 locationNCT07051850
Recruiting
Immunotherapy in Lymphoma
Relapsed/refractory High Grade B Cell Lymphoma
Sung-Soo Park72 enrolled2 locationsNCT06796517
Recruiting
Phase 1
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Acute Lymphoblastic Leukemia
Guangzhou Women and Children's Medical Center10 enrolled1 locationNCT06752785